These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1507762)

  • 1. [Organization of early diagnosis of colorectal cancer].
    Vladimirov VA; Kikot' VA
    Klin Khir (1962); 1992; (5):43-6. PubMed ID: 1507762
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal cancer screening by primary care physicians in Texas: a rural-urban comparison.
    Hawley ST; Foxhall L; Vernon SW; Levin B; Young JE
    J Cancer Educ; 2001; 16(4):199-204. PubMed ID: 11848667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting.
    Janda M; Hughes KL; Auster JF; Leggett BA; Newman BM
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1661-7. PubMed ID: 20880176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention is better than cure: guidelines for colorectal cancer screening are missing the mark.
    Tan KY; Seow-Choen F
    Colorectal Dis; 2007 Nov; 9(9):784-6. PubMed ID: 17931168
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of participation in colorectal cancer screening with faecal occult blood testing.
    von Euler-Chelpin M; Brasso K; Lynge E
    J Public Health (Oxf); 2010 Sep; 32(3):395-405. PubMed ID: 20015868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mass screening for colorectal cancer using occult blood studies. From theoretic efficacy to generalized practice].
    Launoy G; Herbert C
    Rev Epidemiol Sante Publique; 1997 Apr; 45(2):177-8. PubMed ID: 9221447
    [No Abstract]   [Full Text] [Related]  

  • 10. Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: the experimental and pilot phases of the Lazio program.
    Federici A; Barca A; Baiocchi D; Quadrino F; Valle S; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2008 Sep; 8():318. PubMed ID: 18803810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occult blood in the stool as a screening test for colo-rectal cancer and precancerous polyps. Field study on 815 adults].
    Gnauck R
    Z Gastroenterol; 1974 Jun; 12(4):239-50. PubMed ID: 4428814
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of screening for tumors of the digestive system].
    Franceschi S; Segnan N
    Ann Ist Super Sanita; 1996; 32(4):621-7. PubMed ID: 9382431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening in colorectal cancer: soon to be a reality?].
    Faivre J; Bedenne L; Arveux P; Milan C; Durand G
    Rev Med Suisse Romande; 1990 Jun; 110(6):501-6. PubMed ID: 2367786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
    Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Logan RF
    Gut; 2008 Sep; 57(9):1333; author reply 1333-4. PubMed ID: 18719146
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet for fecal occult blood test screening: help or harm?
    Fletcher RH
    Eff Clin Pract; 2001; 4(4):180-2. PubMed ID: 11525106
    [No Abstract]   [Full Text] [Related]  

  • 18. [Colorectal cancer screening should be evaluated in Swedish studies].
    Blom J
    Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence, efficacy and effectiveness of screening for colorectal cancer with faecal tests.
    Faivre J; Lepage C
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S17-9. PubMed ID: 18368633
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical inquiries. At what age do patients no longer need colorectal cancer screening?
    Tatum P; Mehr D; Easton B
    J Fam Pract; 2001 Jul; 50(7):575-6. PubMed ID: 11485702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.